Trials / Conditions / ACC
ACC
4 registered clinical trials studyying ACC — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma NCT06066333 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma NCT01898715 | Millendo Therapeutics, Inc. | Phase 1 |
| Completed | A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands NCT01678105 | Ontario Clinical Oncology Group (OCOG) | Phase 2 |
| Completed | A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) NCT01262235 | Arbutus Biopharma Corporation | Phase 1 / Phase 2 |